Bowser continued with the cautious approach she has taken over the past several months and said there is little D.C. could do ...

Reiterating timelines for FDA submission in 2025Transplant clinical trial has attracted leading transplant hospitalsBooked first revenue from first-generation GraftAssureIQ research-use-only kits; beg ...

CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $439 millionCARVYKTI® demonstrated positive long-term outcomes in CARTITUDE-1 study with one-third of patients remaini ...

This D.C. protest has survived seven presidents, countless global conflicts and historic natural disasters. Now, a Republican ...